Matches 1 - 50 out of 78 1 2 >


Match Document Document Title
US20110144006 PROTEIN COMPOSITION  
The invention relates to a protein composition which upon ingestion by a healthy person with a normal fasting insulin level between 3.0-8.0 μU/L increases the insulin level to at most 20.0 μU/L....
US20140141078 Dissolvable TableT  
A dissolvable tablet is disclosed. The tablet includes a front side, an obverse side and a thickness between the front side and the obverse side. The front side and obverse side have a variation...
US20110300216 Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives  
A tablet comprising: (a) an active ingredient; and (b) at least one member of an effervescent couple, wherein said tablet dissolves in water in not more than three minutes and in the mouth in not...
US20110236480 PREBIOTIC FORMULATIONS AND METHODS OF USE  
The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein...
US20130202699 PHOSPHATE BINDER FORMULATION FOR SIMPLE DOSING  
The invention relates to a pharmaceutical composition in the form of pourable granules or a chewable tablet containing at least one phosphate binding substance and at least one effervescent agent....
US20130280327 ZOLPIDEM-BASED ORODISPERSIBLE PHARMACEUTICAL TABLET  
The present invention is directed to oral pharmaceutical forms for rapid disintegration which make it possible to prevent possible misuse of the zolpidem present therein. The present invention...
US20110038929 ORAL CARE PET PRODUCT AND METHOD  
An effervescent composition for reducing breath odors and preventing and/or reducing plaque buildup, deposits and/or formation on the teeth of pet animals. The effervescent composition includes at...
US20070003613 Preparations to support maintenance of acid-alkaline balance in the human body and methods directed to using same  
The present invention provides novel compositions in the form of a powder, capsule, liquid or lozenge, and methods for administering said novel compositions to assist the body in its ability to...
US20140030326 EFFERVESCENT FORMULATIONS COMPRISING DEXKETOPROFEN  
The present invention relates to water-soluble formulations comprising the active agent dexketoprofen and to a process for production of said formulations. The present invention also relates to...
US20140271849 Abuse Deterrent Solid Dosage Form for Immediate Release with Functional Score  
The present disclosure provides an immediate release, abuse deterrent pharmaceutical solid dosage form comprising at least one functional score. In particular, the immediate release, abuse...
US20060073202 Dual component medicament delivery system  
A medicament delivery system is disclosed. The system comprises a descending formulation for delivering the medicament and an ascending formulation to protect a patient being treated with the...
US20110189278 PTEROSTILBENE COCRYSTALS  
Cocrystals of pterostilbene are disclosed, including: pterostilbene:caffeine cocrystal, pterostilbene:carbamazepine cocrystal, pterostilbene:glutaric acid cocrystal, and pterostilbene:piperazine...
US20110189277 PTEROSTILBENE COCRYSTALS  
Cocrystals of pterostilbene are disclosed, including: pterostilbene:caffeine cocrystal, pterostilbene:carbamazepine cocrystal, pterostilbene:glutaric acid cocrystal, and pterostilbene:piperazine...
US20110189276 PTEROSTILBENE COCRYSTALS  
Cocrystals of pterostilbene are disclosed, including: pterostilbene:caffeine cocrystal, pterostilbene:carbamazepine cocrystal, pterostilbene:glutaric acid cocrystal, and pterostilbene:piperazine...
US20110189275 PTEROSTILBENE COCRYSTALS  
Cocrystals of pterostilbene are disclosed, including: pterostilbene:caffeine cocrystal, pterostilbene:carbamazepine cocrystal, pterostilbene:glutaric acid cocrystal, and pterostilbene:piperazine...
US20070087053 Lozenge for treatment of dry mouth and related conditions  
A composition and method for the treatment of dry mouth (xerostomia), comprising a sialogogic compound in combination with an effervescent organic acid-based buffering system.
US20080175888 Combination Therapy Comprising Actinidia and Steroids and Uses Thereof  
Disclosed is a combination of an Actinidia preparation and one or more steroids, and the use of such a combination to prevent and/or treat allergic and non-allergic inflammatory conditions or...
US20120114753 MULTI-LAYER TABLET COMPRISING EFFERVESCENT LAYER  
The present invention provides a multi-layer tablet comprising: an effervescent layer comprising hydrochlorothiazide or amlodipine or its salt as an active ingredient, a carbonate salt, and an...
US20070059362 Effervescent rehydrating beverage tablet/granules  
Effervescent tablets, powders and granules are provided which may be dissolved in water to produce an effervescent rehydrating beverage. The effervescent tablet, powder and granule compositions of...
US20070104785 TABLETS OF LINEZOLID FORM III AND PROCESSES FOR THEIR PREPARATION  
The present invention relates to solid oral dosage forms of linezolid polymorphic Form III with reproducible dissolution profile and processes for their preparation. The solid dosage form includes...
US20070087054 EFFERVESCENT FORMULATIONS OF OXYTOCIN  
An effervescent formulation comprising oxytocin, preferably comprising multilayer effervescent microspheres containing an acidic substance, a basic substance and water-soluble isolating agent. An...
US20050008699 Effervescent glucosamine composition  
Disclosed is an effervescent composition that includes glucosamine, at least one component of an effervescent couple, and optionally chondroitin, and dissolves in excess water to form at least a...
US20130280326 PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION INTENDED TO PREVENT MISUSE  
The present invention is directed to oral pharmaceutical forms, the composition of which makes it possible to prevent possible misuse of the active principle present therein. The present invention...
US20060039973 Effervescent composition including water soluble dietary fiber  
An effervescent composition that includes granulated water soluble dietary fiber comprising branched oligosaccharide including no greater than 10 sugar units, and an effervescent couple including...
US20050158381 Effervescent composition including cranberry extract  
Disclosed is an effervescent composition that includes an effervescent agent and cranberry extract, preferably in an amount sufficient to decrease the measurable amount of bacteria present in the...
US20080254079 NOVEL COMPOSITIONS CONTAINING LYSOZYME AND C-1/C-4 POLYSACCHARIDES AND USE THEREOF IN ORAL CARE, COSMETOLOGY AND DERMATOLOGY, CONTRACEPTION, UROLOGY AND GYNECOLOGY  
A composition comprising a content of a lysozyme and a content of a C-1/C-4 polysaccharide is useful in oral care, cosmetology and dermatology, contraception, urology and gynecology. It is...
US20060057078 Oral care tablet  
A water soluble, non-abrasive, effervescent, pharmaceutically acceptable, oral care tablet for use in the oral cavity. The tablet includes a carbon dioxide source, a acid source and a tablet...
US20070071818 EFFERVESCENT FORMULATIONS COMPRISING APOMORPHINE  
An effervescent formulation comprising apomorphine, preferably comprising multilayer effervescent microspheres containing an acidic substance, a basic substance and water-soluble isolating agent....
US20070036853 Generally linear effervescent oral fentanyl dosage form and methods of administering  
Fentanyl containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than know oral formulation and have advantages in terms of...
US20070281014 Prednisolone salt formulations  
The present invention relates to tablets containing prednisolone salts and in particular prednisolone sodium phosphates. The tablets include ODTs and non-ODTs, effervescent tablets and...
US20050142198 Effervescent oral fentanyl dosage form and methods of administering fentanyl  
Fentanyl-containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than known oral formulation and have advantages in terms of...
US20050163838 Effervescent oral opiate dosage forms and methods of administering opiates  
Opiate containing dosage forms and methods using same are described. These dosage forms include substantially less opiates by weight than known oral formulations. These dosage forms are intended...
US20090280172 GALENIC FORMULATIONS OF ORGANIC COMPOUNDS  
The present invention relates to a dosage form for transmucosal administration comprising a therapeutically effective amount of aliskiren or a pharmaceutically acceptable salt thereof, and an...
US20080317855 Particulate Compositions Comprising Alginate and/or Alginic Acid  
An ingestible particulate composition comprises: a. an alginate and/or alginic acid; b. a bicarbonate and/or carbonate; c. an organic acid; and d. an agglomerant, being a compound, such as a low...
US20070071817 Effervescent oral care compositions and method of use  
Solid effervescent compositions are described. The solid compositions include an edible acid and a carbonate salt (e.g., sodium carbonate or sodium bicarbonate). The compositions can further...
US20050042287 Skin preparation composition  
According to one aspect of the present invention a composition comprises a intermediate and a diluent. About 2.8% to about 22.2% by weight of the intermediate comprises surfactant system and about...
US20090099142 PHARMACEUTICAL COMPOSITIONS COMPRISING ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE AND METHOD OF USING SAME  
The present invention relates generally to pharmaceutical compositions comprising esterified estrogens, methyltestosterone and one or more pharmaceutical excipients. Methods for preparing and...
US20080166396 Boronate Medicaments Suitable for Short Duration Anticoagulation  
An oral dosage form of a compound selected from boronic acids which have a neutral thrombin (P1) domain linked to a hydrophobic moiety capable of binding to the thrombin (S2) and (S3) subsites,...
US20070281015 Anti-acid pharmaceutical composition in powder form and process for making it  
An anti-acid pharmaceutical composition for the rapid and prolonged neutralization of gastric acidity with mucosa-protecting activity in powder form to prepare, by dispersion in water, a...
US20070218131 EFFERVESCENT FORMULATIONS COMPRISING DESMOPRESSIN  
An effervescent formulation comprising desmopressin, preferably comprising multilayer effervescent microspheres containing an acidic substance, a basic substance and water-soluble isolating agent....
US20060039972 Effervescent composition including a grape-derived component  
The invention features an effervescent composition that includes at least one grape-derived component, at least one effervescent agent, and optionally at least one active agent, where the sum of...
US20060039971 Effervescent composition including alternative hormone replacement therapy agent  
An effervescent composition including at least 0.5% by weight of an herbal extract selected from the group consisting of red clover extract, black cohosh extract, sage extract and combinations...
US20100047344 PERFORMANCE ENHANCING COMPOSITION AND USE THEREOF  
The performance of a mammal, manifested as a reduced oxygen uptake (VO2) during physical exercise, can be enhanced by administering to said mammal a non-toxic amount of nitrate and/or nitrite....
US20140356420 MICRO-PARTICLE COMPRISING A PROTEIN EXTRACT FROM SWEET POTATO FOR EXTENDING SATIETY AND CONTROLLING BLOOD GLUCOSE AND LIPID LEVELS  
The present invention relates to a micro-particle for extending satiety and controlling blood glucose and lipid levels, comprising a core having the protein extract from sweet potato, an active...
US20070031490 Effervescent powders for inhalation  
Effervescent powders comprising inhalable particles are disclosed, as are methods for preparing these powders. The inhalable carrier particles comprise an inorganic or organic carbonate, and an...
US20080175897 Dosage forms for administering combinations of drugs  
The present invention is directed to dosage forms that can be used in therapeutic methods involving the oral co-administration of a combination of at least two drugs, one of which impairs...
US20060228412 (-)-Hydroxycitric acid for delaying gastric emptying  
The inventors have discovered that food and pharmaceutical compositions containing (−)-hydroxycitric acid, its salts, amides and esters can be employed for delaying gastric emptying and increasing...
US20090220595 COMBINATION OF ERYTHROPOIETIN GLYCOISOFORMS  
This invention relates to a combination of erythropoietin glycoisoforms, wherein such glycoisoforms may include a quantity of sialic acid ranging from 4 to 10 molecules of sialic acid per molecule...
US20080102116 Quick Dissolve Medicament and Method of Manufacturing  
A medicament core which contains a super disintegrant or an effervescent couple including a foaming agent and a pharmaceutically acceptable acid activator, which core is partially covered by...
US20090041842 Partly Neutralised Anionic (Meth) Acrylate Copolymer  
The invention relates to a partly neutralised anionic (meth)acrylate copolymer consisting of radically polymerised units containing 25-95% by weight (meth)acrylic acid C1 to C4 alkylesters and...

Matches 1 - 50 out of 78 1 2 >